Fall 2021 - Spring 2022 Grand Rounds

Location: Zoom
Time: Thursdays, 12:00 PM–1:00 PM
Intended Audience: Internal MGH Faculty and Staff
Course Directors: Colin D. Weekes, MD, PhD; David P. Ryan, MD

The Massachusetts General Hospital Cancer Center Grand Rounds program has emerged as a premiere oncology conference in Boston. This program provides an opportunity for Mass General professional staff and fellows to learn from national and international leaders and innovators in cancer treatment and research.

Grand Rounds offers CME credit, and is structured as a 45-minute lecture followed by 15 minutes of discussion and interaction. Please see below to view the weekly topics and presenters. Click on the title to view the presentations (please note not all sessions are available for viewing).

Fall 2021 Grand Rounds Schedule

September 23, 2021
Industry Roundtable: A Conversation About Cancer Equity

Ruma Bhagat, MPH
Senior Science Leader Global Health Equity Strategy
Genentech, Inc.

Patrice Matchaba, MD
Global Head of Corporate Responsibility
Novartis US

Coleman Obasaju, MD, PhD
Senior Medical Director - Oncology
Eli Lilly and Company

David Windsor
Clinical Trials Diversity Ops Lead for Oncology

September 30, 2021
Keynote Address: The Impact of Population and Tumor Heterogeneity in Cancer Genome Science

John D. Carpten, PhD
Professor and Chair of Translational Genomics
Director, Institute of Translational Genomics
Royce and Mary Trotter Chair in Cancer Research
Department of Translational Genomics
Keck School of Medicine of USC

October 7, 2021
DNA Damage Repair Deficient Pancreas Cancer

Talia Golan, MD
Head of Sheba Pancreatic Cancer Center
Sheba Medical Center, Tel HaShomer

October 14, 2021
Clinical Pathologic Conference: A 29-Year-Old Woman with Jaundice and Chronic Diarrhea

Jon Dubois, MD
Medical Oncologist
Massachusetts General Hospital Cancer Center

Jennifer Wo, MD
Radiation Oncology
Massachusetts General Hospital

Avinash Kambadakone, MD
Massachusetts General Hospital

M. Lisa Zhang, MD
Massachusetts General Hospital

October 21, 2021
Utilizing Underlying Tumor Biology to Guide Immunotherapy Drug Development in Sarcoma, One Subtype at a Time

Sandra D’Angelo, MD
Associate Attending Physician
Memorial Sloan Kettering Cancer Center

October 28, 2021
Patient-Centered Care in the Precision Oncology Era

Laura Petrillo, MD
Palliative Medicine
Mass General Cancer Center

November 4, 2021
The Chabner Pioneers in Oncology Lectureship: Getting to the Root of Cancer Health Disparities: A Journey to Health Equity

Michele K. Evans, MD
Deputy Scientific Director & Chief
Health Disparities Research Section
National Institute on Aging
National Institutes of Health

November 11, 2021
Immune-Related Toxicities: Diversity in Clinical Research and Innovation

Jarushka Naidoo, MB, BCH, MHS
Assistant Professor of Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Bloomberg-Kimmel Institute for Cancer Immunotherapy

November 18, 2021
Topic TBD

Diego Castrillon, MD, PhD
Vernie A. Stembridge, MD, Distinguished Chair in Pathology
UT Southwestern Medical Center

December 2, 2021
Debate: Topic TBD

Rebecca Heist, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital

Zofia Piotrowska, MD
Assistant Professor, Medicine
Harvard Medical School
Assistant in Medicine, Medicine
Massachusetts General Hospital

December 9, 2021
Topic TBD

Jill Feldman
Group Founder, EGFR Resisters

December 16, 2021
Topic TBD

Renier Brentjens, MD, PhD
Director, Cellular Therapeutics
Associate Chair, Junior Faculty Development, Department of Medicine
Memorial Sloan Kettering Cancer Center


Previous Grand Rounds

Spring 2021

January 7, 2021
ASH Update

Sharl Azar, MD
Jeffrey Barnes, MD, PhD
Andrew Brunner, MD
Thomas Spitzer, MD
Andrew Yee, MD
Massachusetts General Hospital Cancer Center

January 14, 2021
Cancer Therapeutics and Diagnostics: A View from My Lens

David Schenkein, MD
General Partner, Google Ventures
Adjunct Professor of Medicine, Hematology and Oncology
Tufts Medical Center

January 21, 2021
Unraveling Immune Checkpoint Inhibitor Toxicities

Douglas B. Johnson, MD, MCSI
Assistant Professor of Medicine, Clinical Director, Melanoma
Vanderbilt- Ingram Cancer Center
Vanderbilt University

January 28, 2021
A Functional Genomics Platform for Precision Medicine

Jeffrey W. Tyner, PhD
Professor of Medicine
Department of Cell, Development and Cancer Biology
Oregon Health and Sciences University

February 4, 2021
MGH American Cancer Society Institutional Research Grant (IRG) Awardee Presentations

Deborah Forst, MD
Massachusetts General Hospital Cancer Center

Rachel Jimenez, MD
Massachusetts General Hospital

Christine Chiasson MacKenzie, PhD
Massachusetts General Hospital Cancer Center

February 11, 2021
Refining Disease States in Response to PD-1 Blockade

Matthew D. Hellman, MD
Lung Cancer, Immunotherapy, Clinical Trials
Associate Attending, Hematology/Oncology
Weill Cornell Medical College
Memorial Sloan Kettering Cancer Center

February 18, 2021
CPC: A 49-Year-Old Man with Relapsed Acute Myeloid Leukemia

Richard Newcomb, MD
Dana-Farber Cancer Institute

Andrew Crabbe, MD, PhD
Massachusetts General Hospital

Andrew Brunner, MD
Massachusetts General Hospital Cancer Center

Yi-Bin Chen, MD
Massachusetts General Hospital Cancer Center

March 4, 2021
New Findings in Endocrine Therapy of Breast Cancer

Nancy Davidson, MD
Senior Vice President, Director and Professor
Clinical Research Division, Fred Hutch
Raisbeck Endowed Chair for Collaborative Research
Fred Hutch
President and Executive Director, Seattle Cancer Care Alliance

March 11, 2021
Understanding Responses to Cancer Therapy: The Tissue is the Issue, the Scoop is in the Poop, and You are What You Eat

Jennifer Wargo, MD
MD Anderson Cancer Center

March 18, 2021
Molecular Profiling of Gliomas: Secrets Revealed

Arnab Chakravarti, MD
Chair and Professor, Department of Radiation Oncology
Klotz Family Chair of Cancer Research
Director, Brain Tumor Program
Ohio State University Comprehensive Cancer Center and Richard L. Solove Research Institute
Arthur G. James Cancer Hospital
The Ohio State University Medical School

March 25, 2021
Late Recurrences in Estrogen Receptor Breast Cancer

Daniel F. Hayes, MD, FASCO, FACP
Stuart B. Padnos Professor of Breast Cancer Research
University of Michigan Rogel Cancer Center

April 1, 2021
Debate: Discussion of Incorporation of Radiation Therapy into Management of Localized Pancreas Adenocarcinoma

Ted Hong, MD
Director, Gastrointestinal Service, Department of Radiation Oncology
Associate Clinical Director, Department of Radiation Oncology
Massachusetts General Hospital

Wells Messersmith, MD
Professor, Medicine-Medical Oncology
University of Colorado Anschutz Medical Campus

April 8, 2021
Immunotherapy of Small Cell Lung Cancer: What is Next?

Taofeek Owonikoko, MD, PhD
Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine

April 15, 2021
Junior Faculty Lecture: Regulatory Drivers in Cancers

Esther Rheinbay, PhD
Assistant Professor of Medicine
Massachusetts General Hospital Cancer Center

Liron Bar-Peled, PhD
Assistant Professor, Medicine
Harvard Medical School
Investigator, Center for Cancer Research
Massachusetts General Hospital

April 22, 2021
Looking Beyond Scopes, Scans, and Smears: The Future of Cancer Screening

Sana Raoof, MD, PhD
Medical Resident
Massachusetts General Hospital

April 29, 2021
Development of Epigenetic Therapy in GI Malignancies

Nita Ahuja, MD, MBA, FACS
William H. Carmalt Professor of Surgery
Chair, Department of Surgery
Interim Director, Yale Cancer Center
Interim Physician-in-Chief, Smilow Cancer Hospital

Nilo Azad, MD
Associate Professor of Oncology
Johns Hopkins University

May 6, 2021
State of Cancer in America: 2021

Clifford A. Hudis, MD
CEO, American Society of Clinical Oncology

May 13, 2021
Next Gen Immunotherapy Strategies in Prostate Cancer: Can Immunocytokines Succeed Where PD1/PDL1 Inhibitors Have Not?

Ravi A. Madan, MD
Clinical Director, Genitourinary Malignancies Branch
National Institutes of Health

May 20, 2021
CPC: A 25-Year-Old Man with Visual Changes, Thrombocytopenia, and B Cell-ALL

Zack DeFilipp, MD
Dept. of Medicine, MGH

Annabelle Anandappa, MD
Dept. of Medicine, MGH

Karen Rodriguez, MD
Dept. of Radiology, MGH

Judith Ferry, MD
Dept. of Pathology, MGH

May 27, 2021
Oncolytic Immunovirotherapy against Glioma: From the Bench to the Clinic and Back

Evanthia Galanis, MD
Medical Oncologist, Brain Tumor Program
Mayo Clinic

Fall 2020

September 17, 2020
The Chabner Pioneers in Oncology Lectureship: Lung Cancer Therapy

Paul Bunn, MD
Medicine-Medical Oncology
James Dudley Chair in Cancer Research
Professor, Lung Cancer
University of Colorado Hospital

September 24, 2020
COVID Response: Lessons Learned from the COVID Surge at MGH and What to Expect for the Future

Kerry Reynolds, MD
Clinical Director, Inpatient Oncology Units
Director, Severe Immunotherapy Complications Program
Massachusetts General Hospital Cancer Center

Paul Biddinger, MD
Chief, Division of Emergency Preparedness
Director, MGH Center for Disaster Medicine

Anne Prestipino, MPH
Senior Vice President of Strategy and Clinical Operations
Massachusetts General Hospital Cancer Center

October 1, 2020
COVID Response: Using Registries to Inform Risk Assessment and Care Delivery for Individuals with Cancer During the COVID-19 Pandemic

William Wood, MD
Associate Professor of Medicine, Division of Hematology
UNC School of Medicine

October 8, 2020
COVID Response: Temporal and Spatial Heterogeneity of SARS-CoV-2 Pulmonary Infection

David Ting, MD
Assistant Physician, Hematology/Oncology
Massachusetts General Hospital Cancer Center

October 15, 2020
21st-Century Impact of Cancer Care

Robert Winn, MD
Senior Associate Dean for Cancer Innovation
VCU School of Medicine

October 22, 2020
Me Biased? Unconscious Bias in Medicine and Medical Education

Narjust Duma, MD
Hematology/Oncology Faculty
Department of Medicine
School of Medicine and Public Health
University of Wisconsin

October 29, 2020
Clinical Pathologic Conference: 34-Year-Old Woman with Abdominal Distension, Fatigue, and Acute Kidney Insufficiency

Sundar Jagannath, MD
Mount Sinai Hospital, NYC

Mark Anderson, MD
Department of Radiology
Massachusetts General Hospital

Andrew Yee, MD
Massachusetts General Hospital Cancer Center

Robert Hasserjian, MD
Department of Pathology
Massachusetts General Hospital

November 5, 2020
How Many Myelomas Are There?

Nikhil Munshi, MD
Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center
Dana-Farber Cancer Institute

November 12, 2020
Heparin-Induced Thrombocytopenia: Still with us. Still a problem.

Douglas Cines, MD
Professor of Medicine, Professor of Pathology and Laboratory Medicine
University of Pennsylvania Perelman School of Medicine
Director, Coagulation Laboratory

November 19, 2020
Lippard Lecture

Diego Castrillon, MD
Vernie A. Stembridge, M.D., Distinguished Chair in Pathology
Harold C. Simmons Comprehensive Cancer Center
UT Southwestern Medical Center

December 3, 2020
Chief Fellows Lecture

Chi-Joan How, MD
Medical Oncology Fellow
Dana-Farber Cancer Institute

Connor Johnson, MD
Medical Oncology Fellow
Dana-Farber Cancer Institute

Chris Nabel, MD
Medical Oncology Fellow
Massachusetts General Hospital Cancer Center

December 10, 2020
Debate: Time to De-Escalate Treatment in Oropharyngeal Carcinoma?

Lori Wirth, MD
Medical Director, Center for Head and Neck Cancers
Massachusetts General Hospital Cancer Center

Barbara Burtness, MD
Professor of Medicine
Disease Aligned Research Team Leader, Head and Neck Cancers Program
Co-Leader, Developmental Therapeutics
Yale Cancer Center

Annie Chan, MD
Director, Head and Neck Radiation Oncology Research Program
Massachusetts General Hospital

John Clark, MD
Clinical Director, Center for Head and Neck Cancers
Massachusetts General Hospital Cancer Center

Jeremy Richmon, MD
Director, Head and Neck Robotic Surgery
Massachusetts Eye and Ear